Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
CI

CI - Cigna Corp Stock Price, Fair Value and News

338.77USD-0.49 (-0.14%)Market Closed

Market Summary

CI
USD338.77-0.49
Market Closed
-0.14%

CI Alerts

  • 2 major insider sales recently.
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

CI Stock Price

View Fullscreen

CI RSI Chart

CI Valuation

Market Cap

96.2B

Price/Earnings (Trailing)

24.97

Price/Sales (Trailing)

0.47

EV/EBITDA

14.21

Price/Free Cashflow

8.28

CI Price/Sales (Trailing)

CI Profitability

EBT Margin

1.94%

Return on Equity

9.32%

Return on Assets

2.52%

Free Cashflow Yield

12.08%

CI Fundamentals

CI Revenue

Revenue (TTM)

206.0B

Rev. Growth (Yr)

23.08%

Rev. Growth (Qtr)

12.01%

CI Earnings

Earnings (TTM)

3.9B

Earnings Growth (Yr)

-116.23%

Earnings Growth (Qtr)

-119.15%

Breaking Down CI Revenue

Last 7 days

-2.8%

Last 30 days

-2.1%

Last 90 days

-0.7%

Trailing 12 Months

32.1%

How does CI drawdown profile look like?

CI Financial Health

Current Ratio

0.83

Debt/Equity

0.75

Debt/Cashflow

0.37

CI Investor Care

Dividend Yield

1.5%

Dividend/Share (TTM)

5.09

Buy Backs (1Y)

3.99%

Diluted EPS (TTM)

12.19

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024206.0B000
2023183.0B186.1B189.9B195.3B
2022177.1B179.5B180.4B180.5B
2021162.9B166.8B170.1B174.1B
2020154.1B154.5B156.9B160.4B
201975.2B102.5B129.6B153.6B
201842.8B43.9B45.0B48.6B
201740.3B40.8B41.3B41.8B
201600039.8B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Cigna Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 15, 2024
eder noelle k
acquired
149,962
171
875
see remarks
May 14, 2024
agoglia hoeltzel mary t
sold
-2,073,450
348
-5,946
svp tax & chief acct. officer
May 14, 2024
eder noelle k
acquired
948,273
171
5,533
see remarks
May 14, 2024
agoglia hoeltzel mary t
acquired
718,842
120
5,946
svp tax & chief acct. officer
May 14, 2024
eder noelle k
sold
-3,728,630
348
-10,700
see remarks
Apr 24, 2024
ozuah philip
acquired
-
-
539
-
Apr 24, 2024
zarcone donna f
acquired
-
-
539
-
Apr 24, 2024
mcclellan mark b.
acquired
-
-
539
-
Apr 24, 2024
mazzarella kathleen m
acquired
-
-
539
-
Apr 24, 2024
granger elder
acquired
-
-
539
-

1–10 of 50

Which funds bought or sold CI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 17, 2024
CITIZENS FINANCIAL GROUP INC/RI
reduced
-0.11
501,248
2,871,280
0.10%
May 17, 2024
New Covenant Trust Company, N.A.
new
-
21,065
21,065
0.02%
May 17, 2024
Kozak & Associates, Inc.
sold off
-
-45.00
-
-%
May 17, 2024
Advisory Resource Group
added
3.5
900,712
4,429,170
1.02%
May 17, 2024
Aspect Partners, LLC
unchanged
-
1,275
7,264
0.01%
May 17, 2024
Plato Investment Management Ltd
added
1,571
4,483,350
4,716,020
0.49%
May 16, 2024
Global Financial Private Client, LLC
unchanged
-
23,849
134,346
0.06%
May 16, 2024
Ancora Advisors LLC
unchanged
-
46,009
262,161
0.01%
May 16, 2024
LBP AM SA
added
116
5,375,650
8,687,870
0.35%
May 16, 2024
Redwood Investment Management, LLC
sold off
-100
-662,000
-
-%

1–10 of 44

Are Funds Buying or Selling CI?

Are funds buying CI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CI
No. of Funds

Unveiling Cigna Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
8.47%
24,775,082
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 25, 2024
blackrock inc.
8.4%
24,554,544
SC 13G/A
Feb 14, 2023
dodge & cox
3.8%
11,548,557
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
4.5%
13,656,608
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G
Feb 09, 2023
vanguard group inc
8.37%
25,583,766
SC 13G/A
Feb 07, 2023
blackrock inc.
9.0%
27,469,496
SC 13G
Feb 14, 2022
dodge & cox
5.3%
17,484,197
SC 13G
Feb 14, 2022
price t rowe associates inc /md/
5.4%
17,961,332
SC 13G/A

Recent SEC filings of Cigna Corp

View All Filings
Date Filed Form Type Document
May 16, 2024
4
Insider Trading
May 16, 2024
4
Insider Trading
May 14, 2024
144
Notice of Insider Sale Intent
May 14, 2024
144
Notice of Insider Sale Intent
May 09, 2024
144
Notice of Insider Sale Intent
May 03, 2024
144
Notice of Insider Sale Intent
May 02, 2024
10-Q
Quarterly Report
May 02, 2024
8-K
Current Report
Apr 26, 2024
8-K
Current Report
Apr 26, 2024
8-K
Current Report

Peers (Alternatives to Cigna Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
482.9B
379.5B
9.53% 9.48%
31.44
1.27
12.96% -25.81%
96.2B
206.0B
-2.11% 32.08%
24.97
0.47
12.55% -43.95%
84.6B
66.7B
3.80% 15.55%
15.46
1.27
9.59% -4.59%
72.4B
360.9B
-15.92% -16.78%
9.89
0.2
9.07% 78.49%
41.7B
155.5B
8.44% 18.66%
15.24
0.27
6.34% 84.42%
12.3B
12.3B
9.53% 38.52%
15.03
0.99
5.77% 58.74%
11.9B
14.7B
11.04% 30.82%
14.63
0.81
7.99% 19.23%
MID-CAP
8.5B
2.3B
-6.47% 5.37%
30.15
3.73
5.96% 18.29%
6.2B
3.0B
-5.49% -7.73%
-545.12
2.06
10.92% -104.06%
2.3B
1.5B
9.06% 20.53%
36.62
1.57
19.34% 40.15%
2.2B
3.5B
4.01% -38.44%
15.49
0.64
-27.67% -62.43%
SMALL-CAP
1.8B
1.1B
14.53% 25.72%
27.59
1.67
11.45% 30.74%
1.3B
3.0B
6.97% 85.25%
-7.66
0.44
4.98% 4.88%
54.5M
-
-4.17% -6.33%
-3.61
-
- -1.05%
22.0M
21.6M
16.05% 23.93%
39.79
1.02
9.04% -50.63%

Cigna Corp News

Latest updates
Defense World39 hours ago
Yahoo Canada Finance15 May 202401:40 pm
Yahoo News UK14 May 202408:48 pm
Yahoo Finance12 Apr 202407:00 am
Yahoo Finance27 Mar 202407:00 am

Cigna Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue12.0%57,25551,11449,04848,58646,51745,75345,28145,47844,00645,67944,28843,13140,97141,71240,95539,26538,46938,24538,55638,81937,946
  S&GA Expenses-8.8%3,7054,0623,7883,4343,5383,4843,1513,2643,2753,6443,0932,9963,2793,9663,3013,4073,3983,9573,4133,3803,303
EBITDA Margin-19.8%0.04*0.05*0.06*0.07*0.07*0.07*0.07*0.06*0.06*0.06*0.09*0.09*---------
Interest Expenses8.0%336311387310322306308307308303311308331327369348395388392488377
Income Taxes131.7%291-9193913742951367134113551824244223421,236406529208277409348416
Earnings Before Taxes-58.0%79.001881,8401,8841,6011,3583,4911,9811,5671,3202,0591,8981,5135,3781,8042,2891,3971,2611,7631,7581,788
EBT Margin-31.4%0.02*0.03*0.04*0.04*0.05*0.05*0.05*0.04*0.04*0.04*0.06*0.06*---------
Net Income-119.2%-2121,1071,4491,5101,3061,2222,7781,5701,2121,1381,6351,4761,1714,1421,3981,7601,1899771,3541,4101,372
Net Income Margin-32.0%0.02*0.03*0.03*0.04*0.04*0.04*0.04*0.03*0.03*0.03*0.05*0.05*---------
Free Cashflow229.9%4,8401,4672,5162,1824,7181,7892,9739341,7203,9651,809-606---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets0.2%153,119152,761149,645150,054147,976143,885144,209152,630152,610154,889154,251154,207152,081155,451160,044159,628154,711155,774154,847154,401154,348
  Current Assets16.1%43,35737,35134,51834,71132,02730,12230,17037,42235,39336,13425,48725,01125,55427,79934,55734,88030,87729,84521,16820,70921,136
    Cash Equivalents8.5%8,4847,8228,4979,5857,9355,9247,1174,4684,4695,1233,5403,8786,5444,1575,4067,1854,452-4,5773,6104,976
  Inventory-18.0%4,6305,6454,4164,5144,2114,7774,0173,7813,5003,7223,0203,0422,9193,1652,6572,7122,5652,6612,1602,2982,382
  Net PPE------------------4,4174,4484,5384,523
  Goodwill0.0%44,25844,25945,81045,81145,81145,81145,80745,81045,80445,81146,05646,06344,63544,64844,68544,59044,58444,60244,46244,44944,537
Liabilities5.0%111,769106,410103,879104,528103,38099,13199,076106,663106,446107,705106,768105,440103,867105,065111,946112,223109,590110,395110,114110,552111,897
  Current Liabilities6.7%51,97748,71647,05947,34544,72741,22541,11545,21843,66243,57236,34034,71133,47036,02243,88642,17940,38040,13834,44731,86732,969
  Long Term Debt10.3%31,05328,15528,09428,11529,12428,10028,09030,98431,01331,12531,60931,60631,56829,54529,53731,77432,14731,89334,04136,88537,571
Shareholder's Equity-10.5%41,35046,22345,69145,46444,51844,67544,80645,70146,14546,97647,42748,71648,15550,18948,03947,37145,08645,34444,69943,81842,413
  Retained Earnings-1.6%40,97841,65240,98239,93638,84137,94037,04134,62633,42032,59331,80330,51329,38928,57524,44023,05221,29820,16219,18517,83416,426
  Additional Paid-In Capital-1.2%30,29230,66930,56330,43630,33230,23329,39529,93029,73629,57429,07729,40329,25428,97528,77728,69928,55428,30628,11527,89127,855
Shares Outstanding------------------372373378379
Minority Interest704.8%16921.0011.0019.0016.0013.0042.0030.0022.0018.0012.007.006.007.007.005.007.006.003.003.005.00
Float----82,800---82,800---80,800---68,900---59,400-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations229.9%4,8401,4672,8262,4925,0282,0993,2831,2442,0304,2752,119-2961,0934,2948953,2741,8872,7932,4611,0393,192
Cashflow From Investing-12.5%-495-440-1,337-414-2,983-6164,446-408-324123-710-2,307-7174,420-938-237-269-271-304-634475
Cashflow From Financing-102.3%-2,529-1,250-2,572-435-37.00-2,636-5,517-916-2,171-2,371-1,728-62.00-4,051-4,721-1,682-312-1,818-1,707-1,173-1,773-2,534
  Dividend Payments-100.0%-358362362368334341352357324330342345--15.00-----
  Buy Backs639.3%4,0225446241549621,7333,5001,0061,3681,4212,6119162,7941,6901,028368956447674404462
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

CI Income Statement

2024-03-31
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues  
Premiums$ 11,603$ 11,025
Net investment income290277
TOTAL REVENUES57,25546,517
Benefits and expenses  
Pharmacy and other service costs41,43131,459
Medical costs and other benefit expenses9,4409,046
Selling, general and administrative expenses3,7053,538
Amortization of acquired intangible assets423459
TOTAL BENEFITS AND EXPENSES54,99944,502
Income from operations2,2562,015
Interest expense and other(322)(358)
Loss on sale of businesses(19)0
Net realized investment losses(1,836)(56)
Income before income taxes791,601
TOTAL INCOME TAXES291295
Net (loss) income(212)1,306
Less: Net income attributable to noncontrolling interests6539
SHAREHOLDERS' NET (LOSS) INCOME$ (277)$ 1,267
Shareholders' net (loss) income per share  
Basic (in dollars per share)$ (0.97)$ 4.28
Diluted (in dollars per share)$ (0.97)$ 4.24
Pharmacy revenues  
Revenues  
Revenues$ 42,036$ 32,144
Fees and other revenues  
Revenues  
Revenues$ 3,326$ 3,071

CI Balance Sheet

2024-03-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Assets  
Cash and cash equivalents$ 8,439$ 7,822
Investments1,108925
Accounts receivable, net20,56317,722
Inventories4,6305,645
Other current assets2,2632,169
Assets of businesses held for sale6,3543,068
Total current assets43,35737,351
Long-term investments16,02517,985
Reinsurance recoverables4,6724,835
Property and equipment3,6073,695
Goodwill44,25844,259
Other intangible assets30,49130,863
Other assets3,2933,421
Separate account assets7,4167,430
Assets of businesses held for sale, non-current02,922
TOTAL ASSETS153,119152,761
Liabilities  
Current insurance and contractholder liabilities5,7885,514
Pharmacy and other service costs payable24,28419,815
Accounts payable8,1188,553
Accrued expenses and other liabilities8,8579,955
Short-term debt1,7152,775
Liabilities of businesses held for sale3,2152,104
Total current liabilities51,97748,716
Non-current insurance and contractholder liabilities10,64110,904
Deferred tax liabilities, net7,0297,173
Other non-current liabilities3,6533,441
Long-term debt31,05328,155
Separate account liabilities7,4167,430
Liabilities of businesses held for sale, non-current0591
TOTAL LIABILITIES111,769106,410
Contingencies — Note 16
Redeemable noncontrolling interests0107
Shareholders' equity  
Common stock[1]44
Additional paid-in capital30,29230,669
Accumulated other comprehensive loss(2,324)(1,864)
Retained earnings40,97841,652
Less: Treasury stock, at cost(27,769)(24,238)
TOTAL SHAREHOLDERS' EQUITY41,18146,223
Other noncontrolling interests16921
Total equity41,35046,244
Total liabilities and equity$ 153,119$ 152,761
[1]Par value per share, $0.01; shares issued, 402 million as of March 31, 2024 and 400 million as of December 31, 2023; authorized shares, 600 million.
CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
 CEO
 WEBSITEcigna.com
 INDUSTRYHealthcare Plans
 EMPLOYEES65535

Cigna Corp Frequently Asked Questions


What is the ticker symbol for Cigna Corp? What does CI stand for in stocks?

CI is the stock ticker symbol of Cigna Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cigna Corp (CI)?

As of Fri May 17 2024, market cap of Cigna Corp is 96.24 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CI stock?

You can check CI's fair value in chart for subscribers.

What is the fair value of CI stock?

You can check CI's fair value in chart for subscribers. The fair value of Cigna Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cigna Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cigna Corp a good stock to buy?

The fair value guage provides a quick view whether CI is over valued or under valued. Whether Cigna Corp is cheap or expensive depends on the assumptions which impact Cigna Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CI.

What is Cigna Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, CI's PE ratio (Price to Earnings) is 24.97 and Price to Sales (PS) ratio is 0.47. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cigna Corp's stock?

In the past 10 years, Cigna Corp has provided 0.148 (multiply by 100 for percentage) rate of return.